Innovations in DNA Synthesis During COVID-19

This chapter explores how Twist Bioscience adapted to the challenges of the pandemic by developing innovative COVID-19 testing solutions and advancing antibody treatments. It discusses the company’s transition towards biopharma and personalized medicine while emphasizing the importance of strategic partnerships and effective resource management. The speakers highlight the evolution of therapeutics, including the potential of mRNA vaccines and liquid biopsy technology in transforming cancer treatment.